• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form D filed by XWELL Inc.

    1/28/25 4:05:21 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary
    Get the next $XWEL alert in real time by email
    SEC FORM D

    The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
    The reader should not assume that the information is accurate and complete.

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM D

    Notice of Exempt Offering of Securities

    OMB APPROVAL
    OMB Number: 3235-0076
    Estimated average burden
    hours per response: 4.00

    1. Issuer's Identity

    CIK (Filer ID Number) Previous Names
       None
    Entity Type
    0001410428
    XpresSpa Group, Inc.
    Form Holdings, Inc.
    FORM Holdings Corp.
    Vringo Inc.
    X Corporation
       Limited Partnership
       Limited Liability Company
       General Partnership
       Business Trust
       Other (Specify)

    Name of Issuer
    XWELL, Inc.
    Jurisdiction of Incorporation/Organization
    DELAWARE
    Year of Incorporation/Organization
    X Over Five Years Ago
       Within Last Five Years (Specify Year)
       Yet to Be Formed

    2. Principal Place of Business and Contact Information

    Name of Issuer
    XWELL, Inc.
    Street Address 1 Street Address 2
    254 WEST 31ST STREET 11TH FLOOR
    City State/Province/Country ZIP/PostalCode Phone Number of Issuer
    NEW YORK NEW YORK 10001 (212) 750-9595

    3. Related Persons

    Last Name First Name Middle Name
    Ernst Ezra
    Street Address 1 Street Address 2
    254 West 31st Street 11th Floor
    City State/Province/Country ZIP/PostalCode
    New York NEW YORK 10001
    Relationship: X Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):

    President and Chief Executive Officer and Director
    Last Name First Name Middle Name
    Brown Thomas Ian
    Street Address 1 Street Address 2
    254 West 31st Street 11th Floor
    City State/Province/Country ZIP/PostalCode
    New York NEW YORK 10001
    Relationship: X Executive Officer    Director    Promoter

    Clarification of Response (if Necessary):

    Chief Financial Officer
    Last Name First Name Middle Name
    Bernstein Bruce
    Street Address 1 Street Address 2
    254 West 31st Street 11th Floor
    City State/Province/Country ZIP/PostalCode
    New York NEW YORK 10001
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):

    Chairman of the Board
    Last Name First Name Middle Name
    Weinstein Robert
    Street Address 1 Street Address 2
    254 West 31st Street 11th Floor
    City State/Province/Country ZIP/PostalCode
    New York NEW YORK 10001
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Wizenberg Gaelle
    Street Address 1 Street Address 2
    254 West 31st Street 11th Floor
    City State/Province/Country ZIP/PostalCode
    New York NEW YORK 10001
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Lebowitz Michael
    Street Address 1 Street Address 2
    254 West 31st Street 11th Floor
    City State/Province/Country ZIP/PostalCode
    New York NEW YORK 10001
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    4. Industry Group

       Agriculture
    Banking & Financial Services
       Commercial Banking
       Insurance
       Investing
       Investment Banking
       Pooled Investment Fund
    Is the issuer registered as
    an investment company under
    the Investment Company
    Act of 1940?
       Yes    No
       Other Banking & Financial Services
       Business Services
    Energy
       Coal Mining
       Electric Utilities
       Energy Conservation
       Environmental Services
       Oil & Gas
       Other Energy
    Health Care
       Biotechnology
       Health Insurance
       Hospitals & Physicians
       Pharmaceuticals
    X Other Health Care
       Manufacturing
    Real Estate
       Commercial
       Construction
       REITS & Finance
       Residential
       Other Real Estate
      
    Retailing
      
    Restaurants
    Technology
       Computers
       Telecommunications
       Other Technology
    Travel
       Airlines & Airports
       Lodging & Conventions
       Tourism & Travel Services
       Other Travel
      
    Other

    5. Issuer Size

    Revenue Range OR Aggregate Net Asset Value Range
       No Revenues    No Aggregate Net Asset Value
       $1 - $1,000,000    $1 - $5,000,000
       $1,000,001 - $5,000,000    $5,000,001 - $25,000,000
       $5,000,001 - $25,000,000    $25,000,001 - $50,000,000
       $25,000,001 - $100,000,000    $50,000,001 - $100,000,000
       Over $100,000,000    Over $100,000,000
    X Decline to Disclose    Decline to Disclose
       Not Applicable    Not Applicable

    6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

       Rule 504(b)(1) (not (i), (ii) or (iii))
       Rule 504 (b)(1)(i)
       Rule 504 (b)(1)(ii)
       Rule 504 (b)(1)(iii)
    X Rule 506(b)
       Rule 506(c)
       Securities Act Section 4(a)(5)
       Investment Company Act Section 3(c)
       Section 3(c)(1)    Section 3(c)(9)  
       Section 3(c)(2)    Section 3(c)(10)
       Section 3(c)(3)    Section 3(c)(11)
       Section 3(c)(4)    Section 3(c)(12)
       Section 3(c)(5)    Section 3(c)(13)
       Section 3(c)(6)    Section 3(c)(14)
       Section 3(c)(7)

    7. Type of Filing

    X New Notice Date of First Sale 2025-01-14    First Sale Yet to Occur
       Amendment

    8. Duration of Offering

    Does the Issuer intend this offering to last more than one year?
       Yes X No

    9. Type(s) of Securities Offered (select all that apply)

    X Equity    Pooled Investment Fund Interests
       Debt    Tenant-in-Common Securities
    X Option, Warrant or Other Right to Acquire Another Security    Mineral Property Securities
       Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security    Other (describe)

    10. Business Combination Transaction

    Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
       Yes X No

    Clarification of Response (if Necessary):

    11. Minimum Investment

    Minimum investment accepted from any outside investor $0 USD

    12. Sales Compensation

    Recipient
    Recipient CRD Number    None
    GP Nurmenkari Inc. 000153480
    (Associated) Broker or Dealer X None
    (Associated) Broker or Dealer CRD Number X None
    None None
    Street Address 1 Street Address 2
    22 Elizabeth Street
    City State/Province/Country ZIP/Postal Code
    Norwalk CONNECTICUT 06854
    State(s) of Solicitation (select all that apply)
    Check “All States” or check individual States
       All States
       Foreign/non-US
    NEW YORK

    13. Offering and Sales Amounts

    Total Offering Amount $4,000,000 USD
    or    Indefinite
    Total Amount Sold $4,000,000 USD
    Total Remaining to be Sold $0 USD
    or    Indefinite

    Clarification of Response (if Necessary):

    14. Investors

      
    Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
    Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
    2

    15. Sales Commissions & Finder's Fees Expenses

    Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

    Sales Commissions $85,000 USD
       Estimate
    Finders' Fees $0 USD
       Estimate

    Clarification of Response (if Necessary):

    16. Use of Proceeds

    Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

    $0 USD
       Estimate

    Clarification of Response (if Necessary):

    Signature and Submission

    Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

    Terms of Submission

    In submitting this notice, each issuer named above is:
    • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
    • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of:  (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
    • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

    Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

    For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

    Issuer Signature Name of Signer Title Date
    XWELL, Inc. /s/ Ezra Ernst Ezra Ernst President and Chief Executive Officer and Director 2025-01-28

    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

    * This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


    Get the next $XWEL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XWEL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $XWEL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    XWELL and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC Milestone

    NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- XWELL Inc. (NASDAQ:XWEL), a provider of wellness and biosecurity solutions, today announced a strategic partnership with AI and predictive intelligence company PieQ to develop a next-generation U.S. biosecurity forecasting platform in support of the Centers for Disease Control and Prevention (CDC). The announcement follows a recent CDC milestone for the Traveler-based Genomic Surveillance (TGS) program — part of the Biothreat Radar Detection System — which has surpassed one million voluntary participants with XWELL and Ginkgo Biosecurity. Building on this milestone, the collaboration embeds AI-driven forecasting directly into frontline biosecuri

    2/3/26 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor

    NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced the continued expansion of its global biosecurity strategy, leveraging its traveler-based pathogen surveillance capabilities to support international travel hubs and large-scale mass gathering events worldwide. To support this next phase of growth, XWELL announced today that Cindy Friedman, M.D., former CDC senior advisor and the founding director of CDC's Traveler-based Genomic Surveillance (TGS) program, will serve as a senior advisor to the Company. In this role, Dr. Friedman will provide strategic guidance on t

    1/8/26 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Expands Beyond Airports with New Wellness Retail Location in New York City's Pennsylvania Station

    NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- XWELL (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, is excited to announce the opening of its newest location inside New York City's Pennsylvania Station—a major step in expanding the brand beyond airport terminals and into high-traffic city spaces. "Our entry into Penn Station marks a natural next step for XWELL as we continue evolving to meet people where they are," said Ezra Ernst, CEO of XWELL. "Wellness shouldn't be reserved for special occasions or hard-to-reach destinations. With this location, we're embedding accessible self-care into one of the busiest places in America—bringing

    12/18/25 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Ernst Ezra was granted 70,000 shares, increasing direct ownership by 225% to 101,130 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    8/5/25 4:05:23 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Director Wizenberg Gaelle Sandra was granted 89,198 shares, increasing direct ownership by 5,947% to 90,698 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    6/3/25 8:03:22 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Director Lebowitz Michael was granted 98,148 shares, increasing direct ownership by 756% to 111,122 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    6/3/25 8:02:28 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    SEC Filings

    View All

    XWELL Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - XWELL, Inc. (0001410428) (Filer)

    12/18/25 4:37:15 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - XWELL, Inc. (0001410428) (Filer)

    12/5/25 4:05:54 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    SEC Form DEF 14A filed by XWELL Inc.

    DEF 14A - XWELL, Inc. (0001410428) (Filer)

    11/17/25 4:05:28 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wizenberg Gaelle Sandra bought $1,987 worth of shares (1,201 units at $1.65), increasing direct ownership by 402% to 1,500 units (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    9/13/24 5:41:59 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Director Wizenberg Gaelle Sandra bought $551 worth of shares (299 units at $1.84) (SEC Form 4)

    4 - XWELL, Inc. (0001410428) (Issuer)

    7/22/24 8:47:43 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Leadership Updates

    Live Leadership Updates

    View All

    XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor

    NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced the continued expansion of its global biosecurity strategy, leveraging its traveler-based pathogen surveillance capabilities to support international travel hubs and large-scale mass gathering events worldwide. To support this next phase of growth, XWELL announced today that Cindy Friedman, M.D., former CDC senior advisor and the founding director of CDC's Traveler-based Genomic Surveillance (TGS) program, will serve as a senior advisor to the Company. In this role, Dr. Friedman will provide strategic guidance on t

    1/8/26 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Expands Florida Presence with Grand Opening of Waterford Lakes Wellness Center on September 5

    ORLANDO, Fla., Aug. 28, 2025 (GLOBE NEWSWIRE) -- XWELL (NASDAQ:XWEL) ("XWELL" or the "Company"), a leader in wellness solutions for people on the go, is pleased to announce the grand opening of its newest Florida wellness center at Orlando's Waterford Lakes Town Center on Thursday, September 5. The celebration will feature live demonstrations, skincare consultations, and special participation from the Orlando Magic, which recently named XWELL its official wellness spa. You're Invited: Celebrate with UsGuests are invited to join XWELL for an official ribbon-cutting and a first look at the Orlando area's newest destination for self-care: Date: Thursday, September 5Time: 3:00 PM – 7:00 PM E

    8/28/25 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Launches All-New Website, Offering Seamless Booking and Unified Access to Health, Wellness & Beauty Services

    NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL), a leading provider of wellness solutions for people on the go, today unveiled its newly redesigned website — a digital destination that integrates all of the company's services and offerings, allowing customers to discover, book, and engage through a seamless, user-first experience. Accessible at xwell.com, the updated platform unites XWELL's health, wellness, and beauty brands — Xpres Spa®, Naples Wax Center®, XpresCheck®, and HyperPointe™ — under one cohesive experience. Visitors can now explore locations, connect with spa staff, and book services, all in a few clicks. "This new website is a reflection of where XWEL

    7/29/25 8:00:00 AM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by XWELL Inc.

    SC 13D/A - XWELL, Inc. (0001410428) (Subject)

    8/13/24 5:18:44 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by XWELL Inc.

    SC 13G - XWELL, Inc. (0001410428) (Subject)

    8/9/24 4:05:23 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by XWELL Inc.

    SC 13D/A - XWELL, Inc. (0001410428) (Subject)

    7/22/24 6:11:01 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    $XWEL
    Financials

    Live finance-specific insights

    View All

    XWELL Reports Second Quarter 2025 Results

    NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced results for the second quarter ended June 30, 2025. From providing critical biosecurity support to building tech-forward wellness spaces in transportation hubs and local communities, XWELL currently is on a growth trajectory. Through its portfolio of in-airport and off-airport brands, the Company is reimagining what it means to access wellness. Operating Highlights Revenue for the 2025 second quarter totaled $7.7 millionCost of sales decreased approximately 5% from the 2024 second quarterGeneral and administrativ

    8/14/25 4:30:31 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL, Inc. to Report Second Quarter 2025 Results on Thursday, August 14, 2025

    NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced that it will report second quarter 2025 financial results on Thursday, August 14, 2025, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m. ET. The Company encourages investors, and interested parties, to listen via webcast, as there is a limited capacity to access the conference call by dialing 1-412-317-6026. The live and later archived webcast can be accessed from the Investor Relations section of the Company's website at https://www.xwell.com. Visitors to the

    8/13/25 4:30:42 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary

    XWELL Reports First Quarter 2025 Results, Advancing Mission to Liberate Science-Proven Wellness

    NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a pioneer in science-proven, accessible wellness, today reported results for the first quarter ended March 31, 2025. With a growing portfolio of in-airport and off-airport wellness brands, XWELL continues to redefine what wellness access looks like --connecting high-impact, science-backed care to everyday consumers wherever they are. From leading the nation's biosecurity response to building tech-forward wellness spaces in transportation hubs and neighborhoods alike, XWELL is extending wellness beyond the elite and into real life. Operating Highlights: Reported first quarter 2025 revenue of $

    5/20/25 4:15:18 PM ET
    $XWEL
    Other Consumer Services
    Consumer Discretionary